美股A股
StockGist

AxoGen, Inc.

AXGNNASDAQ · Healthcare · Medical - Devices
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves.
$55.93+0.96%
报价 2026-11-13
市值
$3.34B
EV
$3B
PE (TTM)
–
预期 PE (FY2026)
101.0x
52 周区间距高点 -4.6%
$23.57$58.63

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中≈ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.4x0.47 → 0.71(1.5x)79.3
FY+32028-121.7x0.47 → 0.97(2.1x)57.5

毛利率 74% · TTM 收入 $267M · 基数 EPS 0.47(调整后)

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
AXGNAxoGen, Inc.$3.34B+1.0%+29.4%74.8%––202.9x
TNDMTandem Diabetes Care, Inc.$1.4B+14.6%+7.6%56.5%–––
TSHATaysha Gene Therapies, Inc.$1.33B-2.6%-67.8%94%–––
OPKOPKO Health, Inc.$1.25B+0.6%-29.7%48.9%–26.2x–
IARTIntegra LifeSciences Holdings Corporation$1.12B+0.3%+0.8%51%88.0x12.4x16.0x
IRMDIRadimed Corporation$1.09B+0.4%+11.5%76.8%56.2x42.1x42.1x
AHCOAdaptHealth Corp.$1.05B-2.7%-10.0%15.4%–37.6x13.0x
INMDInMode Ltd.$763.6M+0.6%–77.8%10.7x5.3x–Cheap
SANASana Biotechnology, Inc.$605.3M+0.5%–0%–––
同行中位数––-4.6%53.8%56.2x26.2x16.0x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$75.8M$69.7M$61.5M$59.9M$60.1M$56.7M$48.6M$49.4M
Gross Margin74.8%72.7%75.2%74.1%76.6%74.2%71.9%76.1%
Operating Margin1.3%-3.1%-4.6%-16.3%3.2%3%-3.4%4.1%
Net Income$2.3M$-1.5M$-19.6M$-13.2M$708,000$579,000$-3.8M$450,000
Diluted EPS0.04-0.03-0.38-0.280.010.01-0.080.01
Operating Cash Flow$16.5M$1.5M$1.6M$3M$3.2M$7.7M$-13.2M$8.7M

研究材料